Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Salim Yusuf; Marc A. Pfeffer; Karl Swedberg; Christopher B. Granger; Peter Held; John J.V. McMurray; Eric L. Michelson; Bertil Olofsson; Jan Östergren

doi:10.1016/s0140-6736(03)14285-7

Keywords

CandesartanEjection fractionMedicineHeart failureCardiologyInternal medicineHazard ratioPlaceboMyocardial infarctionStroke (engine)Angiotensin IIACE inhibitorAngiotensin-converting enzymeConfidence intervalBlood pressure

Affiliated Institutions

Related Publications

Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction

James B. Young , Mark E. Dunlap , Marc A. Pfeffer +15 more

Background— Patients with symptomatic chronic heart failure (CHF) and reduced left ventricular ejection fraction (LVEF) have a high risk of death and hospitalization for CHF det...

2004 Circulation 393 citations

A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Lars Køber , Christian Torp‐Pedersen , Jan E. Carlsen +10 more

Long-term treatment with trandolapril in patients with reduced left ventricular function soon after myocardial infarction significantly reduced the risk of overall mortality, mo...

1995 New England Journal of Medicine 1765 citations

Assessing diagnosis in heart failure: which features are any use?

Andrew Davie

We assessed the value of symptoms, past history, medications and signs in the evaluation of patients who might have heart failure secondary to left ventricular systolic dysfunct...

1997 QJM 195 citations

Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure

Milton Packer , Robert M. Califf , Marvin A. Konstam +4 more

Background— Combined inhibition of the angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) may produce greater benefits in heart failure than ACE inhibition alon...

2002 Circulation 623 citations

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.

Robert Ader , Kanu Chatterjee , Thomas A. Ports +3 more

The hemodynamic effects of an oral angiotensin-converting enzyme inhibitor, captopril, were evaluated in 10 symptomatic patients with chronic congestive heart failure. In all pa...

1980 Circulation 292 citations

Publication Info

Year: 2003
Type: article
Volume: 362
Issue: 9386
Pages: 777-781
Citations: 2927
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2927

OpenAlex

Cite This

APA Style

                            
                                
                                    Salim Yusuf, 
                                
                                    Marc A. Pfeffer, 
                                
                                    Karl Swedberg
                                
                                et al.
                            
                            (2003). 
                            Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. 
                            The Lancet
                            , 362
                            (9386)
                            , 777-781.
                            https://doi.org/10.1016/s0140-6736(03)14285-7
                        

Identifiers

DOI: 10.1016/s0140-6736(03)14285-7